4//SEC Filing
William Arsani 4
Accession 0001209191-23-047773
CIK 0001807120other
Filed
Aug 29, 8:00 PM ET
Accepted
Aug 30, 6:02 PM ET
Size
10.1 KB
Accession
0001209191-23-047773
Insider Transaction Report
Form 4
William Arsani
Director
Transactions
- Purchase
Common Stock
2023-08-28$2.15/sh+275,000$591,250→ 1,040,000 total(indirect: By Logos Global Master Fund LP) - Purchase
Common Stock
2023-08-29$2.44/sh+1,960,000$4,782,400→ 3,000,000 total(indirect: By Logos Global Master Fund LP)
Holdings
- 1,217,627(indirect: By Logos Opportunities Fund II, L.P.)
Common Stock
- 814,874(indirect: By Logos SPV 1 LP)
Common Stock
Footnotes (4)
- [F1]The weighted average purchase price for the transaction was $2.15. The shares were purchased at a range of prices between $2.11 and $2.1677, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]Logos GP LLC ("Fund GP") is the general partner of Logos Global Master Fund LP (the "Fund"). The Reporting Person is the Managing Member of Fund GP. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]The weighted average purchase price for the transaction was $2.44. The shares were purchased at a range of prices between $2.29 and $2.50, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F4]Logos Global Management LP is the investment advisor of private funds, including Logos Opportunities Fund II LP ("LOF II") and Logos SPV 1 LP ("SPV 1"). Logos Opportunities GP LLC ("GP I") is the general partner of LOF II. Logos Opportunities II GP LLC ("GP II") is the general partner of SPV 1. The Reporting Person is the Managing Member of both GP I and GP II. The Reporting Person disclaims beneficial ownership of these securities except to the extent of Reporting Person's pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Design Therapeutics, Inc.
CIK 0001807120
Entity typeother
Related Parties
1- filerCIK 0001848372
Filing Metadata
- Form type
- 4
- Filed
- Aug 29, 8:00 PM ET
- Accepted
- Aug 30, 6:02 PM ET
- Size
- 10.1 KB